Laboratory Tests for Diverticulitis
Obtain a complete blood count (CBC), C-reactive protein (CRP), and consider procalcitonin in patients with suspected diverticulitis to assess severity and guide management decisions.
Essential Laboratory Tests
The core laboratory workup for suspected diverticulitis should include:
Complete Blood Count (CBC): Leukocytosis (WBC >15 × 10⁹ cells/L) is present in approximately 90% of cases and indicates a higher risk of progression to complicated disease 1, 2. This is a critical risk stratification marker.
C-Reactive Protein (CRP): Elevated CRP, particularly >140 mg/L, identifies patients at increased risk for progression to complicated diverticulitis 1. Recent evidence shows CRP has good predictive performance (AUC 0.755) for distinguishing mild from severe disease 3.
Procalcitonin: This biomarker demonstrates superior predictive performance (AUC 0.795) compared to CRP for early risk stratification, with an optimal cut-off value of 0.095 ng/mL 3. While not universally mentioned in older guidelines, this represents the most recent high-quality evidence for severity assessment.
Additional Laboratory Studies
Basic Metabolic Panel: Assess for dehydration, electrolyte abnormalities, and renal function, particularly important when considering antibiotic selection and hydration needs 4.
Urinalysis: Helps exclude urinary tract infection or identify complications such as colovesical fistula 4.
Risk Stratification Using Laboratory Values
High-risk features requiring antibiotic therapy include:
- WBC count >15 × 10⁹ cells/L
- CRP >140 mg/L
- Procalcitonin >0.095 ng/mL
- ASA score III or IV
- Immunocompromised status 1, 3
Clinical Context and Pitfalls
Common pitfall: Relying solely on clinical presentation without laboratory confirmation. The misdiagnosis rate based on clinical criteria alone is high 5. Laboratory testing combined with CT imaging provides the most accurate diagnostic approach.
Important caveat: Immunocompromised patients (corticosteroid use, chemotherapy, transplant recipients) may present with milder signs and symptoms despite severe disease 1. Maintain a low threshold for comprehensive laboratory evaluation and imaging in these patients.
The biomarker-guided approach, particularly incorporating procalcitonin alongside CRP and WBC count, enables reliable early identification of severe diverticulitis and enhances clinical decision-making regarding antibiotic selection, hospitalization needs, and surgical consultation 3, 6.